---
$id: https://graph.org.ai/products/commodity/51263103
$type: Product
source: UNSPSC
code: "51263103"
title: "Adimolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Adimolol

**UNSPSC Code**: 51263103
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C25H29N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B6CJY5K2ST, chemically known as (rs)-2,3-dihydro-1-(3-(2-hydroxy-3-(naphthyloxy)propylamino)-3-methylbutyl)-1h-2-benzimidazolon but generally known as adimolol, which bears US NIH Compound Identifier 71227. Adimolol most often comes in forms base, hydrochloride, and hydrate. European Medicines Agency schedules Adimolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05270MIG. The term ADIMOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). ADIMOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule adimolol under HS 29339990 and SITC 51577. As of Q4 2014, ADIMOLOL remains the US FDA Preferred Term for this commodity. Adimolol bears US NLM identifiers UMLS ID C0050843 and NCI Concept Code C73013. SMILES: OC(CNC(CCN1C2C([NH]C1=O)CCCC2)(C)C)COC1C2C(CCC1)CCCC2.

